Official data from INPI

122022013119

ArquivadaUtility ModelPCT · EP2013052617

Talk to an expert

Application data

Number

122022013119

Type

Utility Model

Filing

02/08/2013

Publication

PCT

EP2013052617

View on INPI

Progress at the INPI

Filing02/08/13
Publication
Abandoned
Allowance
Grant
In force

The application was abandoned at the INPI. The case ended without a patent and the technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/25/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

NOGRA PHARMA LIMITED

See this company's full portfolio

Inventors

No inventors listed.

Technical data

IPC Classification

No IPC classification.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Manutenção do arquivamento

#11.20

10/25/2022

RPI 2703

11.12

Dividido do PCT 11 2014 019399-1

08/09/2022

RPI 2692

Requerimento de pedido de patente

#2.10

Número de Protocolo '870220057391' em 30/06/2022 11:23 (WB)

07/12/2022

RPI 2688

From the same holder

112026015224 112025020511 AGENTES ANTISSENSO DE IL-34 E MÉTODOS DE USO DOS MESMOS COMPOSIÇÕES DE OLIGONUCLEOTÍDEOS ANTISSENTIDO SMAD7 (ASO) E MÉTODOS DE USAR AS MESMAS AGENTES ANTISSENSO IL-34 E MÉTODOS DE USAR OS MESMOS OLIGONUCLEOTÍDEO ANTI-SENSO DE PROTEÍNA DE RETARDO MENTAL DO X FRÁGIL (FMRP), SEUS USOS E COMPOSIÇÃO FARMACEUTICAMENTE ACEITÁVEL PROCESSOS PARA PREPARAR COMPOSTOS CAPAZES DE MODULAR A ATIVIDADE DOS RECEPTORES PPARs, DITOS COMPOSTOS E USO TERAPÊUTICO DOS MESMOS OLIGONUCLEOTÍDEOS ANTISSENSO CONTRA IL-34 E MÉTODOS DE USO DOS MESMOS

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.